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Introduction Botulinum toxin is a second-line treatment for
neurogenic detrusor overactivity [1]. The primary objective of this
study was to compare the duration of efﬁcacy of botulinum toxin
intradetrusor injections (BTI) at a dose of 200 IU (only dosage
approved by marketing authorisation (MA) in 2011) versus a dose
of 300 IU (dose previously used).
Methods Retrospective review of a prospective cohort of all
patients receiving BTI between 24 August 2011 (date of MA) and
1st March 2014 in Nantes, divided into 2 groups. Group 1 had
already received BTI at a dose of 300 IU before the MA and group 2
initiated treatment at a dose of 200 IU.
Results One hundred and thirty-four patients were followed for a
mean of 4.7 years. In group 1 (n = 83), the duration of efﬁcacy was
decreased in 49.7% of patients (n = 41) at the 200 IU dose and the
dose was subsequently increased to 300 IU in these patients. In
group 2 (n = 51), 37.3% of patients (n = 19) failed to respond to a
dose of 200 IU and the dose was increased to 300 IU. The mean
duration of efﬁcacy of BTI was signiﬁcantly lower at 200 IU (7.7
months) compared to 300 IU (10.0 months) (P = 0.001598). In
group 1, a shorter previous duration of efﬁcacy at 300 IU was a
prognostic factor for failure of the 200 IU dose (P = 0.0004421).
Conclusion In this study, the duration of efﬁcacy of BTI was
longer at a dose of 300 IU than at a dose of 200 IU. In other studies
this result was not identiﬁed [2], but is worthing discussing
because of the beneﬁt to the patient.
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Objective Our objective was to study the effect of the association
of weight loss intervention and pelvic ﬂoormuscle training (PFMT)
on unirary incontinence (UI) in obese women.
Methods This prospective study included 107 obesewomenwith
urinary incontinence (UI) randomized into three groups: G1
including women who underwent a training program with a low
calorie diet, G2 women who underwent the same training
associated to a PFMT and G3 women without any therapeutic
intervention. An evaluation was realised a week before the
beginning and after 12 months.
Results A reduction of the BMI (body mass index) was noted in
G1 and G2 (P < 0.001). Sixty-six percent of women in G1 and 85.3%
of women in G2 reported that their condition improved. The score
of PFM strength was signiﬁcantly improved only in G2 (P < 0.001).
Only in the two ﬁrst group, we noted a signiﬁcant reduction in the
number of voiding and of leakages per day (P < 0.001), a signiﬁcant
amelioration in the 24-hour pad test (P < 0.001) and a signiﬁcant
improvement of the Urinary Disability Measure (UHM) and the
score of quality of life (P < 0.001). The improvement of all these
parameters was more important in G2 (P < 0.001).
Discussion There are studies that report the effect of either
weight loss intervention or PFMT for treating female UI [1,2].
However, there is no study that reveals whether or not there were
additional effects of addingweight loss intervention to PFMT for UI
in obesewomen. This work shows that the bestmanagement for UI
in obese women must include weight loss intervention and PFMT
with making women aware of their ﬂoor pelvic muscles. However,
the limited nature of follow-up beyond the end of treatmentmeans
that the long-term outcomes of use of PFMT or weight loss
intervention remain uncertain.
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Objective Chikungunya is an arbovirus transmitted by Aedes
mosquitoes. Signiﬁcant epidemics have been reported inReunion in
2005–2006 and the FrenchWest Indies whose Martinique in 2013-
2014. Mainly, Chikungunya is characterized by polyarthralgia and
fever. Patients also related overactive or hypoactive bladder. Those
bladder dysfunctions have been described in literature just one time
by an Indian team [1] in 2006–2007. The purpose of this study is to
identify and describe these disorders.
Methods Patients were enrolled using a screening urinary
disorders questionnaire through Chikungunya consultation in
academic hospital of Fort-de France from January 2015.
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